Even in this famine of corona vaccine across the country is big news. India Biotech has said that it will produce 100 crore dovacin doses a year. The company is optimistic about making that huge number of vaccines. Suchitra Ella, Joint Managing Director of the company said.
In an interview with the international TV channel WION, Suchitra said that the number of vaccines could be produced only if we could strengthen our supply chain with the help of the government. Because with the help of the Ministry of Foreign Affairs, the necessary materials for the vaccine test have to be brought from the United States and Europe.
Is Kovacsin able to fight the Indo-South African corona species?
Kovacin can also control the corona double mutant virus found in India and Africa. It can also fight species from Brazil and Britain.
Read more–A five-judge bench of the High Court constituted in the bail case of Firhad
How far is the trial of covacin in patients aged 2-18 years?
Trials for covacin will begin in June between the ages of 2 and 16. If all goes well, the trial will end in 3 months.
The government has recently announced that 200 crore vaccines will be produced by mid-December. In this case covacin (Covaxin) What is the state of production?
We have 3 vaccine production centers in three places in the country. We can produce 200-250 million doses a year from Hyderabad center, 500 million doses from Bangalore and 200 million doses a year from Ankeshwar. So we are close to producing that one billion dose. As a result, it is very easy to increase the production and reach that one hundred crore.
Problems with the supply chain?
Vaccine (Covid Vaccine) A huge amount of chemicals are required for testing. Most of it comes from Europe and the United States. Some components are also needed to make the vaccine. These parts come from the United States and Europe. As a result, if the supply of these items can be made easier, then the production target can be easily reached.
Read more-How is Bengali in Corona? Buddhadeb wanted to know about the sick body
Vaccines made in India have been sold abroad. How much will it help to get vaccine ingredients from abroad?
The country is always on my mind during this extreme. However, we have to supply orders from foreign countries. We have provided vaccines in 125 countries of the world. Many of those countries are poor. We have to work with everyone at this time. This leads to bilateral cooperation.
Other companies are demanding patents. What do you say?
The production of this vaccine is very complex. Only patent or technical support will not produce. Improved infrastructure is also required for production. The highest level of security is to be complied with. They have to be.
